67 related articles for article (PubMed ID: 9413208)
21. Carcinogenic potential of trans-2-hexenal is based on epigenetic effect.
Nádasi E; Varjas T; Pajor L; Ember I
In Vivo; 2005; 19(3):559-62. PubMed ID: 15875776
[TBL] [Abstract][Full Text] [Related]
22. Deuterium depletion can decrease the expression of C-myc Ha-ras and p53 gene in carcinogen-treated mice.
Gyöngyi Z; Somlyai G
In Vivo; 2000; 14(3):437-9. PubMed ID: 10904878
[TBL] [Abstract][Full Text] [Related]
23. Correlation between expression of mdr-1 gene and oncogenes in human promyelocytic leukemic HL60 cell line and sublines.
Zhou WD; Zhang HQ; Fang M; Xue SB
Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):471-3. PubMed ID: 9863178
[TBL] [Abstract][Full Text] [Related]
24. Effect of different cytostatic protocols on oncogene expression in CBA/Ca mice.
Ember I; Raposa T; Varga C; Kiss I
Anticancer Res; 1995; 15(4):1285-8. PubMed ID: 7654010
[TBL] [Abstract][Full Text] [Related]
25. The effect of aspartame administration on oncogene and suppressor gene expressions.
Gombos K; Varjas T; Orsós Z; Polyák E; Peredi J; Varga Z; Nowrasteh G; Tettinger A; Mucsi G; Ember I
In Vivo; 2007; 21(1):89-92. PubMed ID: 17354619
[TBL] [Abstract][Full Text] [Related]
26. Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model.
Nambiar PR; Giardina C; Guda K; Aizu W; Raja R; Rosenberg DW
Cancer Res; 2002 Jul; 62(13):3667-74. PubMed ID: 12097273
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotype, ras oncogenes and p53 onco-suppressor gene in benzo(a)pyrene induced malignant soft tissue tumours in Wistar rats.
Stefanou DG; Nonni AV; Kalpouzos G; Evangelou A; Agnantis NJ
In Vivo; 1998; 12(5):511-21. PubMed ID: 9827359
[TBL] [Abstract][Full Text] [Related]
28. Copy number of cancer genes predict tumor grade and survival of pancreatic cancer patients.
Nagy A; Kozma L; Kiss I; Ember I; Takacs I; Hajdu J; Farid NR
Anticancer Res; 2001; 21(2B):1321-5. PubMed ID: 11396207
[TBL] [Abstract][Full Text] [Related]
29. Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models.
Jonker MJ; Bruning O; van Iterson M; Schaap MM; van der Hoeven TV; Vrieling H; Beems RB; de Vries A; van Steeg H; Breit TM; Luijten M
Carcinogenesis; 2009 Oct; 30(10):1805-12. PubMed ID: 19696161
[TBL] [Abstract][Full Text] [Related]
30. Histopathological and molecular changes during apoptosis produced by 7H-dibenzo[c,g]-carbazole in mouse liver.
Martín-Burriel I; Roome NO; Dorchies O; Prenez A
Toxicol Pathol; 2004; 32(2):202-11. PubMed ID: 15200158
[TBL] [Abstract][Full Text] [Related]
31. 1-Nitropyrene induces elevated expression of oncogenes and tumor suppressor genes 24 hours after treatment in CBA/Ca mice.
Ember I; Pusztai Z; Gyöngyi Z; Kiss I
Anticancer Res; 2000; 20(3A):1563-6. PubMed ID: 10928071
[TBL] [Abstract][Full Text] [Related]
32. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
Burns TF; Bernhard EJ; El-Deiry WS
Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783
[TBL] [Abstract][Full Text] [Related]
33. Effect of the chalcone analog E,E-bis(2-hydroxybenzylidene) acetone on the 7,12-dimethylbenz[a]anthracene-induced Ha-ras gene activity in vivo.
Perjési P; Ember I; Bozak RE; Nádasi E; Rozmer Z; Varjas T; Hicks RJ
In Vivo; 2006; 20(1):141-6. PubMed ID: 16433043
[TBL] [Abstract][Full Text] [Related]
34. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool.
Luo JL; Yang Q; Tong WM; Hergenhahn M; Wang ZQ; Hollstein M
Oncogene; 2001 Jan; 20(3):320-8. PubMed ID: 11313961
[TBL] [Abstract][Full Text] [Related]
35. Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2.
Hockley SL; Arlt VM; Brewer D; Giddings I; Phillips DH
BMC Genomics; 2006 Oct; 7():260. PubMed ID: 17042939
[TBL] [Abstract][Full Text] [Related]
36. Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens.
Christensen JG; Goldsworthy TL; Cattley RC
Mol Carcinog; 1999 Aug; 25(4):273-84. PubMed ID: 10449034
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiling of p53(+/-) knockout and wild-type mice following diethylstilbestrol administration.
Salleh MN; Ismail P; Abdullah AS; Taufiq-Yap YH
IUBMB Life; 2004 Jul; 56(7):409-16. PubMed ID: 15545218
[TBL] [Abstract][Full Text] [Related]
38. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
39. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
40. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
Cook JL; Miura TA; Iklé DN; Lewis AM; Routes JM
Cancer Res; 2003 Jun; 63(12):3435-43. PubMed ID: 12810682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
